Search Results

Genetic data from nearly 300,000 patients has helped scientists find new potential drug targets for heart disease and diabetes, while shedding more light on the genetics of cholesterol, according to a new study.

Patients with cardiomyopathy have abnormally short telomeres in the cells responsible for heart contraction, Stanford researchers find. This disease hallmark opens new pathways for drug discovery.

Elevated maternal blood sugar when the fetal heart is forming has been linked to a heightened risk for congenital heart defects, according to a new Stanford study.

Infants with the genetic disorders trisomy 13 or 18 are more likely to survive if they undergo heart surgery, a study from researchers at Stanford and the University of Arkansas has found.

Stanford scientists have used a next-generation technology called long-read sequencing to diagnose a patient’s rare genetic condition that current technology failed to diagnose.

A Stanford inquiry into the accuracy of seven wristband activity monitors showed that six out of seven devices measured heart rate within 5 percent. None, however, measured energy expenditure well.

Stanford is leading a multisite study of a new ventricular assist device for children who are awaiting heart transplantation. The miniature pump is slightly bigger than a paper clip.

The donation from philanthropists Gordon and Betty Moore is the largest gift to Lucile Packard Children’s Hospital Stanford since the hospital’s founding gift.

Jose Agredano Jr. got CPR from his mother after being struck in the chest by the ball during a soccer game — an impact that triggered a rare and often lethal medical condition.

Stanford researchers have developed a test that may help screen for cardiotoxicity in new chemotherapy drugs.